Nutriband responds to fentanyl weapon of mass destruction designation
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- S&P 500, Nasdaq climb as AI-linked stocks recover ahead of earnings
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Oil slips from five-month high with Hormuz transits in focus
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
- Brazil's Bolsonaro, Lula spar in first debate as personal attacks fly
- S&P 500, Nasdaq climb as AI-linked stocks recover ahead of earnings
- Glass House Brands posts Q3 revenue of $56.8M, board member exits
- Microsoft pulls out of UK Nscale data centre deal over power delay
- Eos Energy Q3 2026 preliminary revenue up 169% year over year
Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction
December 18, 2025 7:00 AM ESTPrescription pharmaceutical transdermal fentanyl is a valuable treatment for management of pain in opioid-tolerant patients, severe enough to require daily, around-the-clock, long-term opioid treatment for which alternate treatment options are inadequate.
Illicit fentanyl and its core precursor chemicals have been designated as weapons of mass destruction to enable the US government to combat the manufacture and distribution by cartels and foreign networks that have flooded the US with illegal fentanyl.
Nutriband is developing Aversa Fentanyl, an abuse deterrent fentanyl transdermal system, which combines Nutribands proprietary Aversa abuse-deterrent technology with Kindevas FDA-approved fentanyl... More



